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Abstract
Background: Allergies cause a considerable burden to both sufferers and the National Health
Service. There is growing interest in acupuncture as a treatment for a range of conditions. Since
acupuncture may modulate the immune system it could be a useful treatment for allergic rhinitis
(AR) sufferers. We therefore assessed the evidence for the clinical effectiveness of acupuncture in
patients with AR by performing a systematic review of the literature.
Methods: Searches (to 2007) were conducted in all major databases for randomised controlled
trials (RCTs) evaluating the clinical effectiveness of acupuncture in the treatment of AR. No limits
were placed on language. Studies were included if they compared acupuncture to a sham or inactive
acupuncture treatment (placebo) with or without standard care. Meta-analysis was performed
where feasible.
Results: Seven relevant RCTs were included after screening and application of inclusion and
exclusion criteria. The trials were generally of poor quality as assessed by a modified Jadad scale,
with the exception of two studies which scored highly. A wide variety of outcomes was measured
but most assessed symptom severity on a visual analogue scale. A meta-analysis failed to show any
summary benefits of acupuncture treatment for symptom severity scores or serum IgE measures
which could not have been accounted for by chance alone. Acupuncture was not associated with
any additional adverse events in the trials.
Conclusion: There is currently insufficient evidence to support or refute the use of acupuncture
in patients with AR. A large well conducted RCT, which overcomes identified methodological
problems in the existing RCTs, would be required to resolve this question.
Background
Allergies are responsible for an estimated annual
expenditure of £1 billion in the National Health Service
(NHS) [1]. Allergic Rhinitis (AR) is a complex of symp-
toms associated with atopic hypersensitivity reactions to
common allergens including house dust mite, animal
dander and pollens from grasses, trees and weeds. The
prevalence of AR is highest in developed countries. In
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Western Europe, AR is estimated to affect up to 23% of
the population [1-3].
Acupuncture developed from the traditional Chinese
medicine techniques that can trace recorded origins back
to the 2nd century BC [4]. Acupuncture involves the stim-
ulation of acupoints that are located at lines of meridians
that correspond to the flow of energy through the body.
Modern acupuncture has evolved other methods of stim-
ulating acupoints including the use of an electrical cur-
rent, by applying pressure to the acupoint (acupressure)
or using a low intensity laser [5,6]. Complementary and
alternative medicine (CAM) treatments are becoming
increasingly popular in the UK. It is estimated the UK
spends an average of £1.6 billion per year on CAM with
acupuncture the fourth most common treatment behind
aromatherapy, homeopathy and herbal medicines [7].
There is some biological plausibility to the use of acu-
puncture for allergies. A number of small studies suggest
that acupuncture can modulate levels of cytokines and
other anti-inflammatory mediators, although the net
effect of these changes is not necessarily anti-inflamma-
tory nor would they predictably attenuate allergic disease
[8]. Acupuncture can stimulate the release of β endorphin,
which, coupled to the release of adrenocorticotrophic
hormone (ACTH) [9] acts on the adrenal cortex to stimu-
late the release of cortisol, offering another possible anti-
inflammatory effect [5,8-10].
If it were proven to be effective, acupuncture would be an
attractive alternative to conventional symptomatic treat-
ment for some patients. Previous studies have shown that
side effects are rare in acupuncture and generally only
minor, such as irritation at the needle site [11]. The cost of
acupuncture sessions is likely to be comparable to that of
symptomatic medication. In addition many patients dis-
like, and therefore do not adhere to, daily prophylactic
medication use, and a drug-free, safe treatment option
therefore has considerable attractions. In contrast many
health policy makers remain sceptical about acupuncture
and reluctant to commission acupuncture services while
its effect remains unsubstantiated
The aim of this systematic review is to evaluate the evi-
dence of effectiveness of acupuncture for AR.
Methods
Search Strategy
Literature searches were conducted in MEDLINE (1966-
August 2007), EMBASE (1988-August 2007), the
Cochrane library (including DARE and CENTRAL), the
British Library Allied and Complementary Medicines
database (AMED 1985-August 2007) and the National
Research Register for ongoing trials. The specialist acu-
puncture library Acubriefs [12] was searched as was the
Chinese literature via the database provided by the China
National Knowledge Infrastructure (CNKI) website [13].
Index terms for 'acupuncture' 'allergic rhinitis' 'hay fever'
and 'clinical trial' were used (see Additional file 1). The
bibliographies of included studies were searched for addi-
tional references. All studies were collected and organised
using the Refman software package (Version 11, Thomp-
son ISI ResearchSoft).
Study Selection
Randomised controlled trials (RCTs) of acupuncture treat-
ment for patients with AR were included in this review.
RCTs were the only study design chosen to minimise any
potential for bias where non-objective or patient reported
outcomes are used in studies. Inclusion criteria were kept
as broad as possible to include subjects with persistent AR
(seasonal or perennial) with or without other allergies
such as asthma. Patients of any age were included. Any
form of acupuncture treatment that stimulates an acu-
point was included such as solid needles, electro-acu-
puncture and laser acupuncture. Sham or fake
acupuncture treatment with or without standard care was
the comparator. Any outcome measure relating to the
effect of treatment was sought including quality of life
(QoL), days off work or school, rhinitis symptom scores,
medication usage score and adverse effects. Studies pub-
lished in any language were included.
Non- RCT evidence, studies investigating patients with
non-allergic rhinitis or without a placebo (sham or inac-
tive acupuncture) control were excluded.
Assessment of methodological quality
A modification of the Jadad scoring system [14] was used
to asses the quality of the evidence found (Table 1). The
scoring system enabled a maximum score of eight for each
study and assessed quality parameters such as baseline
characteristics, blinding, allocation concealment and
drop out rates. A score of 1 was given for each parameter
fulfilled, (with an additional point for adequate descrip-
tion of the method) and 0 for those not fulfilled or where
this could not be assessed.
Data extraction and statistical methods
Data from included studies was extracted using a struc-
tured pro-forma (see Additional file 2). Where possible
the results from studies were summarised quantitatively
using the Revman software package (Version 4.2,
Cochrane Collaboration, Oxford). Data of interest were
continuous measures, so the relevant effects were differ-
ences between the means, summarised as weighted mean
differences or where different scales were used to measure
the same general attribute, standardised mean differences.
Heterogeneity was assessed using the chi2 test and I2 testBMC Complementary and Alternative Medicine 2008, 8:13 http://www.biomedcentral.com/1472-6882/8/13
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for heterogeneity. A random effects model was preferred
where there was marked heterogeneity (I2 > 50%) and a
fixed effects model in other circumstances. A funnel plot
was the intended method of detecting small study and
publication bias if sufficient included studies had been
detected.
Quality assessment and data extraction were completed
independently by two reviewers for English language
studies and singly for non-English language studies. Any
discrepancies were discussed and resolved between
reviewers, but inter-rater reliability was not formally
assessed.
Results
Seven trials met the inclusion criteria (details of study
flow are given in Figure 1). Five trials were published in
English language, two were published in German. Of the
excluded studies two were in English, two in German, two
in Chinese and one in Czech (see Additional file 3).
The majority of trials were conventional RCT's, one trial
was conducted in an experimental setting using a chamber
with a regulated flow of pollen. One trial adopted a cross-
over RCT design (full details of included studies are in
Table 2).
Participants in the studies were recruited either via adver-
tisements in GP practices or in the local media. This vol-
unteer population may not be a true representation of the
general AR suffering population. The participants in trials
were generally adults with the exception of one study
which was set in a paediatric respiratory clinic but
included some adults
The diagnosis of AR was variable: Two studies included
patients with perennial rhinitis, while six studied exclu-
sively patients with seasonal symptoms. Details of diag-
nosis were poorly reported, with no details given in some
studies and others simply confirming that patients had
positive tests for allergies (skin prick tests or specific IgE
measurement) without further details.
The intervention varied considerably across the trials. One
study used pre-seasonal treatment, whereas the others
treated patients when symptomatic. The frequency of
treatment sessions ranged from one to five per week with
a total between two and 16 sessions overall. One trial eval-
uated the use of laser acupuncture compared to needle
acupuncture, but also included a no treatment group
allowing comparison between acupuncture and a control
group. The acupoints selected by practitioners were
detailed in five of the studies. There were 24 different acu-
points used in these trials. A wide range of outcome meas-
ures was used, with the most common being symptom
severity score measured on a visual analogue scale (VAS)
and medication use.
The comparator in trials was a placebo acupuncture treat-
ment that generally involved needling away from the
active site or needling at a more shallow depth with
shorter needles (to avoid stimulating the acupoint).
Trial quality
Only three studies achieved quality scores of greater than
four from a maximum of score of eight (Table 1). All of
the trials were described as randomised but only three of
the seven trials gave details of the method used. Only two
of the trials included information on allocation conceal-
Table 1: Quality Assessment of included studies.
Study Randomisation 
(appropriate 
description?)
Concealment 
(appropriate 
description?)
Patient blinding 
(appropriate 
description?)
Withdrawals and 
dropouts
Comparable 
baseline groups
Total (max 8)
Wolkenstein 1996 
[16] & Horak 1993 
[18] 1998 [17]
1000 * 0 2
Langer & Hauswald 
1989 [19]
1001 0 * 2
Ng et al 2004 [21] 1 (1) 1 (0) 1 (1) 1 1 7
Magnusson et al 2004 
[15]
1 (1) 0 1 (1) 1 0 5
Williamson et al 1996 
[23]
1 (1) 1 (1) 1 (1) 1 0* 7
Petti et al 2002 [20] 1 (0) 0 0 1 1 3
Xue et al 2002 [22] 1 (0) 0 1 (1) 1 0 4
* Information unclear
A score of 1 was given for each parameter fulfilled in the text with an additional point for adequate description of randomisation, allocation 
concealment and blinding. A 0 was scored where no description or detail was given.BMC Complementary and Alternative Medicine 2008, 8:13 http://www.biomedcentral.com/1472-6882/8/13
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ment. Due to the nature of the intervention it is difficult
to tell if the intervention was distinguishable from the
control treatment or not. Blinding of patients and/or out-
come assessors was mentioned in four of the trials. An
intention to treat (ITT) analysis was stated in only one
trial, but even here it was not possible to assess if this had
really been carried out. Losses to follow-up were described
in all trials and were minimal. In three reports the base-
line characteristics of the study groups were not compara-
ble, and in two further studies comparability could not be
adequately assessed from the details given. This may be
due to the low numbers of participants in some trials, but
raises quality concerns. Only one study addressed the
issue of sample size and power.
Symptom severity scores
Five trials reported symptom severity in a way that could
be used in meta-analysis, and in one further study the
authors kindly provided the raw data for meta-analysis
[15]. The study by Wolkenstein et al [16-18] could not be
incorporated as it reported baseline VAS scores with
means and median values, but only reported the out-
comes as medians. One study did not report symptom
severity scores [19] but investigated percentage change in
symptoms from a pre-season level set to 100%. This study
reported a significant change (at the 2% level) in nose
swelling and conjunctivitis after treatment for both acu-
puncture and placebo groups, but did not report a com-
parison between the groups.
There was a high degree of heterogeneity between the
studies when combined in the meta-analysis (Chi2 104.06
p = 0.00001 I2 96.2%) with a total of 160 subjects in the
intervention arm and 188 in the control arm, which was
associated with a non-significant trend in favour of the
intervention, -1.09 (95%CI -2.33 to 0.10) (Figure 2). Two
of the studies have shown a positive treatment effect in
contrast to the other studies and the results are dominated
by one study that has shown a strong treatment effect in
favour of the intervention [20]. This study however was of
uncertain quality; when this study was excluded as a sen-
sitivity analysis, the degree of heterogeneity dropped
(Chi2 16.77 p = 0.002 I2 76.1%) leaving 172 patients in
the intervention arm and 169 in the control arm. The
overall effect estimate continued to show a non-signifi-
cant trend in favour of the treatment of -0.43 (95% CI -
0.89 to 0.02).
Clinical significance of improved symptom severity
It is difficult to interpret the clinical significance of any
magnitude of change in symptom score on a VAS. One
trial correlated the improvement in daily rhinitis score
with a significant increase in the number of symptom free
days (from baseline 3.2 to 12.7 after follow-up in the acu-
puncture group compared to baseline 1.38 to 2.4 in the
control group, p = 0.0001) [21]. The pre-treatment base-
line outcome values of the groups in this trial, although
similar for rhinitis score, were different for symptom free
days and this might confound this conclusion [21].
The results of the Xue et al [22] study were also broken
down to changes in nasal and non-nasal symptoms,
which were both significant. However, this cross-over trial
did not have a wash out phase between the cross-over of
treatments. This design also does not take account of var-
iable pollen counts and resultant symptom severities that
may occur during the course of a pollen season. The
authors did not comment on possible carry-over of treat-
ment effect between phases.
Serum and plasma biomarkers
Two studies included measurement of serum IgE levels
[15,21]. The studies were combined in a meta-analysis
(Figure 3) and included a total of 55 patients in the inter-
vention arm and 57 in the control arm. There was very lit-
tle heterogeneity between these studies (Chi2 0.61 p =
0.32 I2 0%) and the effect estimate was modestly in favour
of the intervention (-0.19) but was not significant (95%
CI -0.56 to 0.18).
One study investigated plasma cytokine levels and found
a reduction in plasma IL-10 levels 24 hours after treat-
Flow of included studies Figure 1
Flow of included studies.
Total number of potential studies identified (excluding 
duplicates) from databases 
78 
Not relevant using 
title and abstract 60
Full paper retrieved for 
more detailed evaluation
18 
Did not satisfy the 
inclusion criteria or 
duplicate publication of 
data 11 
Studies included in final review 
7 RCTS 
Studies included in meta-analysis
Symptom scores  5 
Serum IgE            2 
Unable to use in meta-analysis 
Symptom scores 2 (no measure) 
Serum IgE  5 (no measure)BMC Complementary and Alternative Medicine 2008, 8:13 http://www.biomedcentral.com/1472-6882/8/13
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Table 2: Details of included studies
Author, year, place of 
study
Population Intervention/
Comparator
Outcomes Result summary
Wolkenstein 1996 [16] & 
Horak 1993 [18] 1998 [17]
Germany
18–65 yrs with AR for > 2 
yrs
n = 30 randomised (unclear 
on numbers in each group). 
Mean age 41 yrs.
Needle acupuncture
Placebo needle was placed 
away from defined 
acupoint.
1 session per week, total 9 
sessions.
1) Nasal secretions (30 
mins)
2) Subjective well-being 
VAS (15 mins)
3) Subjective symptom 
score (15 mins)
4) FEV1 (30 mins)
5) Change in the nasal flow 
(15 mins)
6) Daily symptom diary 
(two months)
1) + 5)There was no 
difference in the sum of 
nasal flows between the 
groups
2) There was no difference 
in subjective well being
3) + 6) No difference for 
symptom score measures 
or the daily symptom diary 
scores
4) No difference reported
Langer & Hauswald 1989 
[19]
Germany
Needle Intervention group 
n = 22 mean age 33
Laser intervention n = 26 
no further details
Control group n = 17 no 
further details
Needle acupuncture: 3 
sessions per week total 9 
sessions.
Laser acupuncture: 15 
sessions, 5 times per week, 
3 weeks
Control: as laser but with 
laser inactive.
1) Nasal swelling
2) Flow of watery 
secretions
3) Conjunctivitis
4) Medication use
5) Sneezing
6) Subjective patient report 
of breathing through the 
nose
7) Patient judgment
Placebo, acupuncture and 
laser acupuncture 
significantly reduced nasal 
swelling, flow of watery 
secretions and 
conjunctivitis at the 2% 
significance level
No results were reported 
for subjective patient 
measure of breathing 
through the nose or 
sneezing.
Ng et al 2004 [21]
Hong Kong
> 6 yrs old with symptoms 
for > 4 weeks and other 
allergies at two sites.
Intervention group n = 35 
ave age 11.7
Control group n = 37 ave 
age 11
Needle acupuncture
Control needling at less 
depth 2 sessions per week 
for 8 weeks (16 sessions)
Follow-up 12 weeks
1) Daily rhinitis score
2) Symptom free days
3) Daily relief medication 
score
4) Blood eosinophil count
5) Serum IgE levels
6) Adverse events/
preference
1) significant reduction in 
daily symptom score in the 
intervention group
2) An increase in symptom 
free days in the 
intervention group from 
baseline reported
3–6) There was no change 
in symptom relief scores 
between the groups or the 
serum markers measured.
Magnusson et al 2004 [15]
Sweden
18–50 yrs old
Intervention n = 20 ave age 
35.3
Control n = 20 ave age 
35.3
Needle acupuncture
Control acupuncture away 
from intervention 
acupoints and shallow 
needling 12 sessions of 3 
needling events in 30 mins.
Follow-up 12 months
1) Allergic symptoms 
(VAS)
2) Mediation use
3) Allergic symptom due to 
pollen (VAS)
4) Tiredness during pollen 
season
5) Depression during 
pollen season
6) Impaired ability to work 
(VAS)
7) Serum IgE
1–6) no significant findings 
between intervention and 
control groups for any of 
the outcome measures.
7) Serum IgE levels were 
found to be reduced in the 
intervention group for the 
mugwort allergen, but 
there were differences in 
baseline characteristics 
between the groups.
Williamson et al 1996 [23] 
UK
> 16 yrs with moderate or 
severe symptoms
Intervention n = 51 ave age 
31.9
Control n = 51 ave age 
29.9
Needle acupuncture
Control group – needling 
on the patella
5 minute sessions 3/4 times 
per week
1) Patients in remission
2) Mean weekly symptom 
score
3) Units of medication
4) Perceived effect of 
acupuncture
1)+2) no changes in 
remission of symptoms 
over the course of the 
study or weekly symptom 
score
3) There was no difference 
between medication use 
score
4) There was no difference 
between perceived effectBMC Complementary and Alternative Medicine 2008, 8:13 http://www.biomedcentral.com/1472-6882/8/13
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ment in the active acupuncture arm [20]. Plasma IL-10
levels were shown to be significantly reduced in the inter-
vention group from baseline 138.1 +/- 28.5 ng/ml to 74.9
+/- 21.4 ng/ml (p < 0.05).
Changes in Medication use
One trial reports a significant reduction in drug usage in
the acupuncture group [19]. Pre-season use was set at
100% and in the acupuncture group medication use fell
from 550% to 75% over the pollen season compared to
the placebo group (263% to 88%). Magnusson et al [15]
showed no differences between intervention and control
groups in medication use. Williamson et al [23] showed
no difference in the unit use of medication between
groups.
Adverse events reported in trials
None of the studies reported any severe adverse events
associated with the use of acupuncture.
Discussion
This is, to our knowledge, the first comprehensive review
that has specifically investigated the use of acupuncture in
AR that has followed the standards guidelines of the Qual-
ity of Reporting of Meta-analyses (QUOROM) recom-
mendations for the reporting of systematic reviews and
meta-analysis [24]. There were no restrictions applied to
language and a number of literature databases were
searched using a comprehensive search strategy. It was not
possible to combine the results of all the trials due to the
variety of outcome measures used. Data was obtained
from authors where possible allowing pooling of some
results into a meta-analysis which has not previously been
published in this field. We cannot assess publication bias
statistically in such a small collection of studies.
The quality scores of the studies were generally poor,
although two scored very highly. While some of the stud-
ies pre-date the CONSORT guidelines for reporting RCTs,
omission of such quality data from later studies is a seri-
ous concern. We nonetheless included these in the analy-
sis since they fulfilled our inclusion criteria. Given the
difficulty of performing RCTs in acupuncture all available
data should contribute to a final analysis.
The meta-analysis of AR symptom scores showed no over-
all effect of acupuncture. This conclusion may be con-
founded by the generally low patient numbers and
variable reporting of outcomes. Inclusion of Wolken-
stein's data would have increased the number of patients
analysed, but this was not available in a form that could
be included in our meta-analysis. While there is a trend in
favour of a positive effect of acupuncture, this is largely
attributable to one study which scored poorly on quality
assessment (19). The higher quality studies tended to
show lower overall effects.
Petti et al 2002 [20]
Italy
22–45 yrs with > 2 yrs 
symptoms Group A: 
Plasma reference control. 
Healthy individuals n = 30 
22–42 yrs
Group B1: Intervention. n 
= 30 22–45 yrs
Group B2: Sham 
Intervention n = 30 24–45 
yrs
Group B3: patient control 
no intervention. n = 30 age 
not clear
Needle acupuncture with 
electrostimulation of the 
needle once in place.
In the intervention group 
the needles in points ST36 
and LI4 were 
electrostimulated with 
pulsating waves for 15 
mins.
All sessions lasted ~20 
mins
1) Symptom score (5-point 
scoring system)
2) Serum cytokine 
measurements for IL-2, IL-
6 and IL-10
Measures were taken 2 hrs 
and 24 hrs after treatment
1) Groups B1 and B2 
showed an improvement in 
symptom scores after 
acupuncture despite B2 
receiving sham 
acupuncture.
2) Serum IL-2 cytokine 
levels were increased after 
24 hours in the reference 
control group and group 
B1. However all values 
were still within the normal 
range Serum IL-6 levels did 
not change in any groups 
over the 24 hrs.
Serum IL-10 levels were 
significantly reduced in the 
active intervention group
Xue et al 2002 [22]
Australia
Age range 18–70 years > 2 
years duration
Group A: n = 17 subjects, 
ave age 44
Group B: n = 13 subjects, 
ave age 44
Needle acupuncture 
administered 3 times a 
week for 4 weeks, sessions 
lasted 25 minutes.
Sham group received 
shorter needles.
1) Severity symptom score
2) Relief medication score
3) Side effects
1) There was a significant 
improvement in post 
treatment symptom 
severity scores between 
intervention and control 
groups
2) One patient in each 
group required relief 
medication – no analysis 
was performed.
3) no side effects reported
Table 2: Details of included studies (Continued)BMC Complementary and Alternative Medicine 2008, 8:13 http://www.biomedcentral.com/1472-6882/8/13
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Our inclusion criteria stipulated that studies had to com-
pare acupuncture with a control sham or inactive acu-
puncture (placebo intervention). Interestingly one of the
excluded studies [25] compared acupuncture with stand-
ard care alone. Outcomes measured in this study included
symptom severity and serum IgE, with IL-4 and Interferon
gamma (IFNγ) levels. There was a significant improve-
ment in long term cumulative score of symptom before
and after treatment and a significant decrease of IgE and
IL-4 for the acupuncture and standard care groups, but
this did not reach significance between groups. The effects
of acupuncture may be more marked when compared to a
non-blinded comparator, highlighting the importance of
sham control in acupuncture studies [26].
Other outcome measures such as drug use or QoL were
either poorly reported or not reported across the studies.
Likewise, the measurement of serum and plasma biomar-
kers such as IgE and cytokines was performed in only a
few studies. While some individual studies have reported
significant changes, the biological significance of these
observations is questionable. The report of active acu-
puncture reducing serum levels of IL-10 contradicts evi-
dence from allergen-specific immunotherapy, where
active treatment is associated with an increase in IL-10
production [27]. Overall these measures have not contrib-
uted usefully to the summative assessment of the evidence
for acupuncture in AR. Any future use of such indices in
trials of acupuncture in AR should focus on those which
have been shown to be helpful in trials of proven thera-
peutic modalities such as allergen-specific immuno-
therapy.
A previously published systematic review investigating a
number of CAM treatments for rhinitis and asthma was
identified [28]. The review was published by the interna-
tional board of the Allergic Rhinitis and its Impact on
Asthma (ARIA) collaboration in 2006 [28]. It included
studies on acupuncture, herbal medicines, homeopathy
and physical techniques (including yoga, chiropractic and
educational programs). This large review has attempted to
answer a very broad question. It is limited in the fact that
it only included studies published in the English language
and the searches were only conducted in MEDLINE and
the Cochrane library [28]. The review contained four trials
relevant to acupuncture in rhinitis, three of which are
included in this review (one study included patients with
non-allergic rhinitis so was not included in this review).
The authors note the few RCT data available for AR and
that the majority of studies outside of RCTs are 'not ran-
domised, controlled or descriptive' [28]. By focussing spe-
cifically on acupuncture for AR and using comprehensive
search strategies across all publication languages we have
been able to add to this evidence base by including four
Meta-analysis of five studies investigating a change in symptom severity score Figure 2
Meta-analysis of five studies investigating a change in symptom severity score.BMC Complementary and Alternative Medicine 2008, 8:13 http://www.biomedcentral.com/1472-6882/8/13
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additional RCTs not identified in this previous review,
and combine the results in a meta-analysis. The results of
our review further confirm the previous work and
strengthen the conclusion that there is currently insuffi-
cient high quality evidence to support or refute the use of
acupuncture for AR [28].
Conclusion
It is not possible to recommend acupuncture as a proven
treatment for AR on the basis of published evidence. How-
ever this evidence is derived from inadequate clinical tri-
als. Studies in AR frequently demonstrate marked
improvements in the placebo group, and this means that
large, well-controlled studies are required to demonstrate
true effects. The quality of future trials could be improved
by utilizing the proposed standardised reporting of acu-
puncture studies, similar to the CONSORT statement
[26,29,30] and use of standardised outcome measures for
conventional studies in AR [30]. Given the high preva-
lence of AR, and the popularity of CAMs such as acupunc-
ture, recruitment to such a study should be limited only
by the availability of suitable study centres with the
required expertise in both allergy and acupuncture.
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Author's note
After completing this review the following article was pub-
lished: Xue CC et al Acupuncture for persistent allergic
rhinitis: a randomised, sham-controlled trial. MJA 187
(6): 337-341, 2007[31]
This well conducted trial evaluated the use of acupuncture
vrs a sham control acupuncture in patients with persistent
AR over an eight week treatment program and 12 week
follow-up period. The authors randomised 42 patients to
active acupuncture and 38 to a sham control group.
The result of this trial was an improvement in cumulative
seven day symptom score (sum of individual scores for
nasal obstruction, sneezing, rhinorrhoea and nasal itch-
ing) between the active and sham acupuncture groups
after treatment (effect size -1.85 in favour of treatment p =
0.01) and at follow-up (effect size -1.87 in favour of treat-
ment p = 0.001) this however did not correlate with any
Meta-analysis of two studies investigating changes in serum IgE levels Figure 3
Meta-analysis of two studies investigating changes in serum IgE levels.BMC Complementary and Alternative Medicine 2008, 8:13 http://www.biomedcentral.com/1472-6882/8/13
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difference in the secondary outcome measure which was
relief medication use.
This trial follows the trend in results highlighted in the
previously published literature with a moderate improve-
ment in symptom severity score which is difficult to inter-
pret in regard to clear clinical benefit. This therefore does
not change the overall conclusions of this review but is
highlighted here in the interest of including the most up
to date information available.
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